secwatch.observer — SEC 8-K summary
======================================

Issuer:     GT Biopharma, Inc. (GTBP)
CIK:        0000109657
Form:       8-K/A
Filed at:   2022-08-17T23:59:59+00:00
Accession:  0001493152-22-023342
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

GT Biopharma amends 8-K to correct vote tabulation on authorized shares reduction
--------------------------------------------------------------------------------

- Proposal 4 to reduce authorized shares from 750M to 250M passed with 19,568,632 For, 215,253 Against, 141,506 Abstain.
- Original filing incorrectly classified Proposal 4 as non-routine; it was routine, allowing broker discretionary votes.
- Company plans special stockholder meeting to ratify inclusion of discretionary broker votes in Proposal 4 tabulation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/109657/000149315222023342/0001493152-22-023342-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/109657/000149315222023342/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-023342

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer